Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: A possible role for HGF in myeloma-associated osteolytic bone disease

Blood

Volumn 94, Issue 11, 1999, Pages 3883-3888

  Hjertner, Øyvind ^a   Torgersen, Maria Lyngaas ^b   Seidel, Carina ^b   Hjorth Hansen, Henrik ^b   Waage, Anders ^b   Børset, Magne ^b   Sundan, Anders ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 11; SCATTER FACTOR;

ARTICLE; BONE DYSPLASIA; BONE REMODELING; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0345534770     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3883     Document Type: Article

References (27)

1. Valentin-Opran A, Charhon SA, Meunier PJ, Edouard CM, Arlot ME: Quantitative histology of myeloma-induced bone changes. Br J Haematol 52:601, 1982
2. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C: Mechanisms of bone destruction in multiple myeloma: The importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 7:1909, 1989
3. Taube T, Beneton MN, McCloskey EV, Rogers S, Greaves M, Kanis JA: Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol 49:192, 1992
4. Børset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A: Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood 88:3998, 1996
5. Børset M, Lien E, Espevik T, Helseth E, Waage A, Sundan A: Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines. J Biol Chem 271:24655, 1996
6. Seidel C, Børset M, Turesson I, Abildgaard N, Sundan A, Waage A: Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. Blood 91:806, 1998
7. Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, Zallone AZ, Comoglio PM: Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA 93:7644, 1996
8. Elias JA, Tang W, Horowitz MC: Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136:489, 1995
9. Girasole G, Passeri G, Jilka RL, Manolagas SC: Interleukin-11 : A new cytokine critical for osteoclast development. J Clin Invest 93:1516, 1994
10. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ: The role of gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 183:2581, 1996
11. Hughes FJ, Howells GL: Interleukin-11 inhibits bone formation in vitro. Calcif Tissue Int 53:362, 1993
12. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597, 1998
13. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ: TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:997, 1998
14. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165, 1998
15. Klein B: Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Semin Hematol 32:4, 1995
16. Børset M, Waage A, Sundan A: Hepatocyte growth factor reverses the TGF-beta-induced growth inhibition of CCL-64 cells. A novel bioassay for HGF and implications for the TGF-beta bioassay. J Immunol Methods 189:59, 1996
17. Børset M, Helseth E, Naume B, Waage A:Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation. Br J Haematol 85:446, 1993
18. Robey PG, Termine JD: Human bone cells in vitro. Calcif Tissue Int 37:453, 1985
19. Børset M, Waage A, Brekke OL, Helseth E: TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line. Eur J Haematol 53:31, 1994
20. Naka D, Ishii T, Shimomura T, Hishida T, Hara H: Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes. Exp Cell Res 209:317, 1993
21. Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC: Transforming growth factor-beta1: Differential effects on multiple myeloma versus normal B cells. Blood 87:1928, 1996
22. Sati HI, Greaves M, Apperley JF, Russell RG, Croucher PI: Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma. Br J Haematol 104:350, 1999
23. Sato T, Hakeda Y, Yamaguchi Y, Mano H, Tezuka K, Matsumoto K, Nakamura T, Mori Y, Yoshizawa K, Sumitani K, Kodama H, Kumegawa M: Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/ PA6). J Cell Physiol 164:197, 1995
24. Fuller K, Owens J, Chambers TJ: The effect of hepatocyte growth factor on the behaviour of osteoclasts. Biochem Biophys Res Commun 212:334, 1995
25. Seidel C, Hjorth-Hansen H, Bendz B, Børset M, Sandset PM, Hansen JB, Sundan A, Waage A: Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals. Br J Haematol 105:641, 1999
26. Barille S, Collette M, Bataille R, Amiot M: Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood 86:3151, 1995
27. Dallas SL, Miyazono K, Skerry TM, Mundy GR, Bonewald LF: Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol 131:539, 1995